SHTDF Stock: Sinopharm Group Co. Ltd. Stock Price, Analysis & Insights
Get live SHTDF stock price $2.29, comprehensive Sinopharm Group Co. Ltd. stock analysis, charts, news, and expert forecast. Real-time SHTDF stock data and investment insights.
Loading chart data...
Sinopharm Group Co. Ltd. (SHTDF) Overview
Sinopharm Group Co. Ltd. (SHTDF) is a publicly traded company in the Healthcare sector , specifically within the Medical - Distribution industry . As of the latest trading session, SHTDF trades at $2.29 with a market capitalization of 7.15B . Over the past 52 weeks, SHTDF has traded between $2.11 and $2.70 , with the current price positioned at approximately 31% of this range . The stock curren...
Key Takeaways
- Operates in the Healthcare sector (Medical - Distribution)
- Market cap: 7.15B
- Current price: $2.29
- 52-week range: $2.11 - $2.70
- P/E ratio: 6.74
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Sinopharm Group Co. Ltd., along with its affiliates, plays a significant role in the People's Republic of China's healthcare sector, primarily engaging in the wholesale and retail trade of pharmaceuticals, medical equipment, and health-related produc...
Company Information
- CEO
- Wanyong Lian
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Employees
- 108217
Contact Information
- Address
- Sinopharm Group Building
- Country
- CN
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 6.7)
✓ Lower volatility stock (Beta: 0.45) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Sinopharm Group Co. Ltd. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Sinopharm Group Co. Ltd.
- ⚠Investors should consider how Sinopharm Group Co. Ltd. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
7.15B
P/E Ratio (TTM)
6.74
Beta
0.45
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare SHTDF with peer companies:
- Price
- $2.67
- Market cap
- 5.20B
- Price
- $10.83
- Market cap
- 5.29B
- Price
- $20.00
- Market cap
- 5.45B
- Price
- $2.34
- Market cap
- 6.20B
- Price
- $18.17
- Market cap
- 7.23B
- Price
- $1.46
- Market cap
- 8.46B
- Price
- $7.60
- Market cap
- 5.64B
- Price
- $12.00
- Market cap
- 5.93B
- Price
- $14.07
- Market cap
- 6.95B
- Price
- $9.03
- Market cap
- 5.61B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.